- Home
- INOD vs BHVN Comparison
INOD vs BHVN Comparison
Compare INOD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- BHVN
- Stock Information
- Founded
- INOD 1988
- BHVN 2013
- Country
- INOD United States
- BHVN United States
- Employees
- INOD N/A
- BHVN N/A
- Industry
- INOD EDP Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- INOD Technology
- BHVN Health Care
- Exchange
- INOD Nasdaq
- BHVN Nasdaq
- Market Cap
- INOD 2.0B
- BHVN 1.9B
- IPO Year
- INOD 1993
- BHVN 2017
- Fundamental
- Price
- INOD $33.04
- BHVN $20.37
- Analyst Decision
- INOD Strong Buy
- BHVN Strong Buy
- Analyst Count
- INOD 4
- BHVN 14
- Target Price
- INOD $55.00
- BHVN $63.15
- AVG Volume (30 Days)
- INOD 1.7M
- BHVN 1.7M
- Earning Date
- INOD 05-08-2025
- BHVN 05-08-2025
- Dividend Yield
- INOD N/A
- BHVN N/A
- EPS Growth
- INOD N/A
- BHVN N/A
- EPS
- INOD 0.89
- BHVN N/A
- Revenue
- INOD $170,461,000.00
- BHVN N/A
- Revenue This Year
- INOD $44.96
- BHVN N/A
- Revenue Next Year
- INOD $20.78
- BHVN $65.26
- P/E Ratio
- INOD $37.12
- BHVN N/A
- Revenue Growth
- INOD 96.44
- BHVN N/A
- 52 Week Low
- INOD $5.46
- BHVN $15.79
- 52 Week High
- INOD $71.00
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- INOD 40.02
- BHVN 39.78
- Support Level
- INOD $34.22
- BHVN $15.79
- Resistance Level
- INOD $39.88
- BHVN $19.30
- Average True Range (ATR)
- INOD 3.73
- BHVN 2.20
- MACD
- INOD 0.19
- BHVN 0.26
- Stochastic Oscillator
- INOD 49.22
- BHVN 42.84
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.